DAX20.903 +1,2%ESt505.148 +0,8%Top 10 Crypto16,57 +0,5%Dow43.488 +0,8%Nas19.630 +1,5%Bitcoin102.349 +0,8%Euro1,0273 -0,3%Öl80,73 -0,8%Gold2.702 ±0,0%
Beliebte Suche
DAX 40 Ölpreis Euro - Dollar Bitcoin - Euro Goldpreis
Meistgesucht
ByteDance BYT111 Trump Media Technology A3CYXD NVIDIA 918422 Novo Nordisk A3EU6F Rheinmetall 703000 Tesla A1CX3T Allianz 840400 Bayer BAY001 BVB (Borussia Dortmund) 549309 BASF BASF11 Deutsche Telekom 555750 Deutsche Bank 514000 Apple 865985 Mercedes-Benz Group (ex Daimler) 710000 Amazon 906866
Alle Aktien für 0 Euro (zzgl. Spreads) handeln mit finanzen.net zero. Hier informieren
Heute im Fokus
DAX geht nach neuem Rekord fester ins Wochenende -- Wall Street schließt im Plus -- NEL ASA kauft Cavendish-Aktien -- Übernahmespekulationen treiben Intel-Aktie an -- Rio Tinto, SUSS im Fokus
Top News
Rohstoffpreise am Sonntagabend Rohstoffpreise am Sonntagabend
Trump lanciert eigenen Krypto-Coin "$TRUMP" Trump lanciert eigenen Krypto-Coin "$TRUMP"
Suche...
Login
ODER

Neu auf finanzen.net?

Kostenfrei registrieren und Vorteile nutzen

Übersicht Wertpapierdepots Musterdepots Watchlists Meine News Newsletter Forum Trading Desk Apps Social Media Podcasts
Profil

DocMorris Aktie

NeuKaufenVerkaufen
22,28 EUR -0,22 EUR -0,98 %
L&S
21,14 CHF +1,37 CHF +6,93 %
SWX
Aktien, ETFs, Sparpläne & Kryptos zu Top-Konditionen beim Testsieger von finanztip.de handeln!
JETZT LOSLEGEN
Du hast schon ein ZERO-Konto? Direkt handeln bei ZERO!Bei einem anderen Broker handelnSmartphone

Marktkap.289,89 Mio. EUR

Div. Rendite0,00%

WKNA0Q6J0

ISINCH0042615283

SymbolZRSEF

DocMorris Aktien News

DatumMeistgelesen
EQS GroupDocMorris accelerates Rx growth
EQS GroupDocMorris grows in the prescription business and invests incrementally in new Rx customers
EQS GroupDocMorris with accelerated and significant eRx growth in new customers, market share and revenue
Wer­bungDocMorris-Aktie für 0 Euro (zzgl. Spreads) handeln bei finanzen.net zero
EQS GroupDocMorris AG: Early redemption of the 2.75% Convertible Bonds due 2025
EQS GroupDocMorris AG: DocMorris announces results of Tender Offer
EQS GroupDocMorris AG: Daniel Wüest becomes new CFO at DocMorris
EQS GroupDocMorris announces the start of the tender offer period for its Outstanding Convertible Bonds due 2025
EQS GroupResolutions of the 31st Annual General Meeting of DocMorris AG of 2 May 2024 in Zurich
EQS GroupFinal allocation of DocMorris CHF 200 million Convertible Bonds Offering
EQS GroupDocMorris successfully completes the placement of CHF 200 million Convertible Bonds due 2029
EQS GroupDocMorris launches approx. CHF 200 million Convertible Bonds due 2029
EQS GroupDocMorris continues to grow in the first quarter of 2024 and creates digital access to the entire e-prescription market
EQS GroupDocMorris AG: DocMorris receives gematik approval for simple digital e-prescription redemption via health card
EQS GroupDocMorris AG: Significant earnings improvement in 2023; e-prescription is standard in Germany
EQS GroupDocMorris achieves significant revenue growth in the fourth quarter of 2023 and confirms inflection point by increasing active customer base
EQS GroupDocMorris optimises organisational structure and prepares for e-prescription growth in Germany
EQS GroupDocMorris strengthens path to profitable growth in third quarter; slightly reduced revenue outlook
EQS GroupDocMorris: Solid basis for sustainable, profitable growth
EQS GroupDocMorris AG: DocMorris demands fully digital non-discriminatory access to e-prescriptions
EQS GroupDocMorris announces results of tender offer for any-and-all of its CHF 200 million outstanding bonds due 2024
EQS GroupDocMorris (formerly Zur Rose Group) announces a tender offer for any-and-all of its CHF 200 million outstanding bonds due 2024
EQS GroupNew stock exchange ticker symbol for DocMorris: DOCM (formerly ROSE)
EQS GroupAnnual General Meeting 2023: Zur Rose Group AG to be renamed DocMorris AG (stock exchange ticker symbol DOCM)
EQS GroupZur Rose Group has successfully completed the sale of its Swiss business to Migros
EQS GroupZur Rose Group: Revenue in the first quarter 2023 in line with plan
EQS GroupZur Rose Group AG publishes invitation to the Annual General Meeting on 4 May 2023
EQS GroupZur Rose Group: Revenue and earnings targets for 2022 achieved; significant step towards profitability
EQS GroupZur Rose Group hands over successful Swiss business to Migros to focus on growth in Germany
EQS GroupZur Rose Group: Revenue target 2022 achieved, EBITDA better than expected
EQS GroupZur Rose Group takes next step towards profitability and further reduces complexity in Germany
EQS GroupProcurement and supply chain brought together under the new Chief Operations Officer
EQS GroupZur Rose Group announces results of Tender Offer
EQS GroupAfter the first nine months, the Zur Rose Group is at the upper end of targets for revenue and EBITDA for 2022
EQS GroupZur Rose Group announces preliminary result and extension of Tender Offer
EQS GroupZur Rose Group announces a tender offer for all of its CHF 115 million outstanding bonds due 2023
EQS GroupFinal allocations of Zur Rose approx. CHF 95 million Convertible Bonds Offering
EQS GroupZur Rose Group successfully completes placement of approx. CHF 95 million Convertible Bonds and the approx. CHF 44 million Capital Increase by way of an accelerated book building process
EQS GroupZur Rose Group launches approx. CHF 100 million Convertible Bonds and approx. CHF 50 million Capital Increase by way of an accelerated book building process
EQS GroupZur Rose Group speeds up path to profitability and plans break-even at EBITDA level in 2023
EQS GroupBetül Susamis Unaran leaves Zur Rose Group
Wer­bung

DocMorris News

DocMorris News: auf dieser Seite finden Sie alle DocMorris News und Nachrichten zur DocMorris Aktie. Dies beinhaltet die Agentur-Feeds auf finanzen.net, aber auch DocMorris News auf einer Vielzahl externer Seiten. Externe Links sind am entsprechenden Link-Symbol zu erkennen. Um DocMorris News auf externen Seiten zu lesen, folgen Sie einfach dem entsprechenden Link.